| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/28/2011 | US20110182810 Central nervous system labelling composition for intranasal administration and labelling method and screening method using central nervous system labelling composition for intranasal administration |
| 07/28/2011 | US20110182807 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent |
| 07/28/2011 | US20110182806 Systems and methods for particle radiation enhanced delivery of therapy |
| 07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
| 07/28/2011 | DE102010005880A1 Contrast agent, useful for imaging tumor diseases e.g. neoplasm of lung, breast, colon or prostate, comprises a construct comprising two copies of a substrate for a tumor-specific protease, and linker with a recognition site for protease |
| 07/28/2011 | CA2788018A1 Device, system and method for quantifying fluorescence and optical properties |
| 07/28/2011 | CA2787753A1 Detection of early-stage pancreatic adenocarcinoma |
| 07/27/2011 | EP2348046A1 NPC1L1 (NPC3) and methods of use thereof |
| 07/27/2011 | EP2348037A1 Method for introducing dota |
| 07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
| 07/27/2011 | EP2347770A2 Process for producing an injectable pharmaceutical preparation |
| 07/27/2011 | EP2346532A2 Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same |
| 07/27/2011 | EP1817061B1 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 07/27/2011 | CN102133409A Sterilizing type medical ultrasonic coupling agent and preparation method thereof |
| 07/27/2011 | CN102133408A Placebo for coronary heart disease |
| 07/27/2011 | CN101658679B Contrast medium of dual-sector targeted magnetic resonance imaging contrast and preparation thereof |
| 07/26/2011 | US7985842 Anti-IGF-I receptor antibody |
| 07/26/2011 | US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 07/26/2011 | US7985402 Ultrasound contrast agent of peptide monomers; peptide vectors having high KDR binding affinity; gas filled microvesicle containing a fluorinated gas and a phospholipid |
| 07/26/2011 | US7985401 Peptides whose uptake by cells is controllable |
| 07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
| 07/26/2011 | CA2485385C Lyophilized edible food incorporating a marker |
| 07/21/2011 | WO2011087000A1 Diagnostic for cancer |
| 07/21/2011 | WO2011086548A2 Targeted delivery systems for diagnostic applications |
| 07/21/2011 | WO2011085603A1 Fe3o4/tio2 composite nano particles, preparation method and application thereof in magnetic resonance imaging contrast agent |
| 07/21/2011 | WO2011051422A3 Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
| 07/21/2011 | WO2011026103A3 Systems and methods for producing hyperpolarized materials and mixtures thereof |
| 07/21/2011 | WO2011011384A9 Synthesis of dendrimer conjugates |
| 07/21/2011 | US20110179502 Modulation of gm98 (mrf) in remyelination |
| 07/21/2011 | US20110179501 Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B |
| 07/21/2011 | US20110178411 Method for determining skin glycation |
| 07/21/2011 | US20110178396 Nicotinamide Derivatives |
| 07/21/2011 | US20110178393 Process for the Preparation of Aqueous Solutions of Hyperpolarized Molecules |
| 07/21/2011 | US20110178368 Method for determining measured data from the stomach of a patient |
| 07/21/2011 | US20110177009 Drug carrier providing mri contrast enhancement |
| 07/21/2011 | US20110177007 Dithienopyrrole Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177006 Dithienofuran Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177005 Stable nanoemulsions for ultrasound-mediated drug delivery and imaging |
| 07/21/2011 | US20110177004 Version of FDG Detectable by Single-Photon Emission Computed Tomography |
| 07/21/2011 | US20110177003 Proteins that fluoresce at infrared wavelengths or generate singlet oxygen upon illumination |
| 07/21/2011 | US20110177002 Cylic polyamines for binding phosphatidylserine |
| 07/21/2011 | US20110177001 Screening assay employing dex and gdf8 |
| 07/21/2011 | US20110177000 Use of S-Nitrosothiol Signaling to Treat Disordered Control of Breathing |
| 07/21/2011 | US20110176999 Palatable liquid dilution vehicles for oral contrast agents |
| 07/21/2011 | US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/21/2011 | CA2787260A1 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery |
| 07/21/2011 | CA2786470A1 Targeted delivery systems for diagnostic applications |
| 07/20/2011 | EP2345669A1 NPC1L1 (NPC3) and methods of use thereof |
| 07/20/2011 | EP2344569A1 X-ray and/or metal detectable articles and method of making the same |
| 07/20/2011 | EP2344205A2 Detection of atherosclerosis using indocyanine green |
| 07/20/2011 | EP2344145A1 Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods |
| 07/20/2011 | EP2344040A1 Molecular imaging |
| 07/20/2011 | CN1954888B Chinese medicine capsule for stomach ultrasonic image |
| 07/20/2011 | CN102126986A Triiodobenzene compound and contrast medium with same |
| 07/20/2011 | CN102125699A Fe3O4/TiO2 composite nano-particles as well as preparation method and application thereof in magnetic resonance imaging contrast medium |
| 07/20/2011 | CN102125698A Method for establishing mouse transplanting tumor model with normal immunologic function |
| 07/20/2011 | CN102125695A Polyglutamate-amino acid conjugates and methods |
| 07/20/2011 | CN101700402B Intestinal wall discriminative gadolinium-contained nano-contrast agent particle and preparation method thereof |
| 07/19/2011 | US7982024 Antibodies to insulin-like growth factor I receptor |
| 07/19/2011 | US7981443 Administration of therapeutically effective amount of topiramate over sleep period of patient |
| 07/19/2011 | US7981400 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
| 07/19/2011 | US7981399 Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium |
| 07/19/2011 | CA2710095C Method for reducing aminoisophthalic acid bisamide related impurities in preparation of non-ionic x-ray contrast agents |
| 07/19/2011 | CA2509035C Contrast media formulations having improved biological tolerance |
| 07/19/2011 | CA2483774C Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 07/19/2011 | CA2465272C Separation of regioisomers of metal phthalocyanines |
| 07/14/2011 | WO2011084625A1 Systems and methods for x-ray flourescence computed tomography imaging with nanoparticles |
| 07/14/2011 | WO2011084458A2 Polymer-based compositions and methods for treatment of peritoneal disorders |
| 07/14/2011 | WO2011083845A1 Targeting agent for tumor site |
| 07/14/2011 | US20110173709 Ectopic, orthotopic model for revascularization and tumor assessment |
| 07/14/2011 | US20110173707 System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity |
| 07/14/2011 | US20110172488 Medico-surgical devices |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172139 Peptides whose uptake by cells is controllable |
| 07/14/2011 | US20110171137 Novel nanostructures and process of preparing same |
| 07/14/2011 | US20110171136 Optical imaging probes |
| 07/14/2011 | US20110171135 Pest-control compositions and methods having high target and low non-target activity |
| 07/14/2011 | US20110171134 (6s)-5-methyltetrahydrofolic acid for therapy of tissue injury |
| 07/14/2011 | US20110171133 Radiolabelled mmp selective compounds |
| 07/14/2011 | US20110171132 Methods, Compounds, and Compositions for Treatment and Prophylaxis in the Respiratory Tract |
| 07/14/2011 | US20110171131 Method of Altering Perception of Time |
| 07/14/2011 | US20110171128 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 07/14/2011 | US20110171124 In situ methods for monitoring the EMT status of tumor cells in vivo |
| 07/14/2011 | US20110171123 In Vivo Biofilm Infection Diagnosis and Treatment |
| 07/14/2011 | US20110171122 Methods and compositions for the detection of cancer |
| 07/14/2011 | CA2836154A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/14/2011 | CA2836153A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/14/2011 | CA2836140A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/13/2011 | EP2343535A1 Fluorescent labeling material and fluorescent labeling agent |
| 07/13/2011 | EP2341944A2 Conjugates of hexose and metal coordinating compounds for imaging purposes |
| 07/13/2011 | EP1601775B1 Rodent model for the fast identification of pharmaceutical active compounds in vivo |
| 07/13/2011 | EP1367886B1 Scce transgenic mice and their use as models of human disease |
| 07/13/2011 | CN1871233B Novel chelating agents and chelates and their use |
| 07/13/2011 | CN102124076A Fluorescent compounds for the diagnosis of infections, production method, and applications thereof |
| 07/13/2011 | CN102124030A Antibody against oxidized ldl/ss2gpi complex and use of the same |
| 07/13/2011 | CN102123738A Method for detecting dysplasia |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/12/2011 | US7979373 Method and system for analyzing drug adverse effects |
| 07/12/2011 | US7977058 Diagnostic method for atherosclerosis |
| 07/12/2011 | CA2349342C Manganese compositions and methods for mri |